CREDIT SUISSE AG/ - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 113 filers reported holding G1 THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.0%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$103,453
-44.9%
38,602
+11.6%
0.00%
Q4 2022$187,81834,589
+3458800.0%
0.00%
Q2 2022$0
-100.0%
1
-100.0%
0.00%
Q1 2022$168,000
-22.9%
22,129
+3.5%
0.00%
Q4 2021$218,000
-40.6%
21,385
-22.0%
0.00%
Q3 2021$367,000
-18.1%
27,412
+34.5%
0.00%
Q2 2021$448,000
-19.1%
20,378
-11.5%
0.00%
Q1 2021$554,000
-57.1%
23,022
-68.0%
0.00%
-100.0%
Q4 2020$1,291,000
+27.6%
71,840
-18.0%
0.00%0.0%
Q3 2020$1,012,000
-8.5%
87,660
+92.2%
0.00%0.0%
Q2 2020$1,106,000
+346.0%
45,603
+103.2%
0.00%
Q1 2020$248,000
-66.6%
22,444
-20.0%
0.00%
-100.0%
Q4 2019$742,000
+30.6%
28,057
+12.5%
0.00%
Q3 2019$568,000
+6.8%
24,949
+43.7%
0.00%
Q2 2019$532,000
+112.8%
17,365
+15.2%
0.00%
Q1 2019$250,000
+14.2%
15,075
+31.3%
0.00%
Q4 2018$219,000
-78.2%
11,481
-40.2%
0.00%
-100.0%
Q3 2018$1,004,000
+34.9%
19,189
+12.1%
0.00%0.0%
Q2 2018$744,000
+154.8%
17,118
+117.4%
0.00%
Q1 2018$292,0007,8740.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
MPM BioImpact LLC 650,000$3,529,5000.92%
CHI Advisors LLC 333,945$1,813,3210.48%
PVG ASSET MANAGEMENT CORP 15,585$84,6260.37%
Rhenman & Partners Asset Management AB 370,000$2,009,1000.21%
NEEDHAM INVESTMENT MANAGEMENT LLC 184,000$999,1200.18%
Birchview Capital, LP 40,000$2170.15%
XTX Topco Ltd 102,282$555,3910.12%
Tekla Capital Management LLC 423,869$2,301,6090.09%
Woodline Partners LP 1,028,967$5,587,2910.08%
Curi Wealth Management, LLC 81,009$439,8790.06%
View complete list of G1 THERAPEUTICS INC shareholders